Global Vaccine Adjuvants Market Size 2024, Forecast To 2033
6 Mar, 2024
The vaccine adjuvants market has demonstrated robust growth, increasing from $1.77 billion in 2023 to $1.91 billion in 2024, with a compound annual growth rate (CAGR) of 8.0%. The growth in the historical period is attributed to increasing vaccine development, the prevalence of infectious diseases, government initiatives and immunization programs, research and development investments, and the globalization of vaccine distribution. Looking ahead to 2028, the market is expected to see strong growth, reaching $2.62 billion at a CAGR of 8.2%. The forecasted expansion is linked to factors such as pandemic preparedness, the expanding vaccine portfolio, global immunization goals, collaborations and partnerships, and a focus on therapeutic vaccines. Major trends in the forecast period include advancements in adjuvant technologies, a focus on immunogenicity enhancement, combination adjuvants for enhanced effectiveness, a demand for safer and well-tolerated adjuvants, and the development of personalized vaccines and adjuvants.
Global Vaccine Adjuvants Market Key Driver
The vaccine adjuvants market is poised for growth due to the rising prevalence of infectious diseases. Infectious diseases, caused by viruses, bacteria, fungi, or parasites, are a global health concern. Vaccines play a crucial role in treating various infectious diseases such as hepatitis B, hepatitis C, HIV, malaria, syphilis, and brucellosis. According to the 2022 World Health Organization (WHO) report, the global burden of infectious diseases remains significant, with millions affected by tuberculosis, HIV, and other infections. This escalating prevalence of infectious diseases serves as a key driver for the growth of the vaccine adjuvants market.
Get A Free Sample Of The Global Vaccine Adjuvants Market ReportGlobal Vaccine Adjuvants Market Segments
The vaccine adjuvants market covered in this report is segmented –
1) By Product Type: Adjuvant Emulsions, Pathogen Components, Particulate Adjuvants, Combination Adjuvants, Other Product Types
2) By Route of Application: Human Vaccine Adjuvants, Veterinary Vaccine Adjuvants
3) By Route of Administration: Oral, Intramuscular, Intranasal, Subcutaneous, Intradermal
4) By Disease: Cancer, Infectious Diseases, Other Diseases
By Geography:The regions covered in the vaccine adjuvants market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain
North America was the largest region in the vaccine adjuvants market in 2023. Asia-Pacific is expected to be the fastest-growing region in the global vaccine adjuvants market report during the forecast period. The regions covered in the vaccine adjuvants market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Major Vaccine Adjuvants Industry Players
GlaxoSmithKline Plc., Novavax Inc., SPI Pharma Inc., Agenus Inc., CSL Limited, InvivoGen Limited., Brenntag Biosector A/S, Adjuvatis, Merck KGaA, Croda International Plc, Seppic Inc, OZ Biosciences, Avanti Polar Lipids Inc, Astellas Pharma Inc, Virometix AG, MPV Technologies Limited, Adjuvance Technologies Inc., Novartis AG, Vaxine Pty Ltd, SBI Biotech Co. Ltd., Statens Serum Institute, GSK Vaccines, VaxLiant LLC, VaxForm LLC, Serum Institute of India, Dynavax Technologies Corporation, Vaxcyte Inc., VBI Vaccines Inc., Medicago Inc., Aphios Corporation
Get The Full Global Vaccine Adjuvants Market Report
Vaccine Adjuvants Market Overview
Vaccine adjuvants are compounds or ingredients used in vaccines that enhance the body's immunogenic response to antigens that lack immunostimulatory capabilities and help to create a stronger immune response.
Vaccine Adjuvants Global Market Report 2023 provides data on the global vaccine adjuvants market such as market size, growth forecasts, segments and geographies, competitive landscape including leading competitors’ revenues, profiles and market shares. The vaccine adjuvants market report identifies opportunities and strategies based on market trends and leading competitors’ approaches.